SCHEMBL6344180

SCHEMBL6344180

Oc1ccc(O)n1-c1cccc2ccoc12

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2266044 0.73 TLR9 (0.50)
Hydrochloric Acid SCHEMBL2263189 0.71 TLR9 (0.48)
SCHEMBL6261842 0.71 ADORA2A (0.42)
SCHEMBL276859 0.71 ADORA2A (0.42)
SCHEMBL28830792 0.70 ADORA2A (0.41)
SCHEMBL8175658 0.69 HTR1A (0.36) HTR1ADRD2
SCHEMBL13239012 0.69 HTR1A (0.53) HTR1ADRD2
SCHEMBL30992343 0.69 HTR1A (0.53) HTR1ADRD2
SCHEMBL5277301 0.68 TDP1 (0.52) HTR1A
SCHEMBL10514753 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050090483-A1 Purine derivatives as kinase inhibitors ELI LILLY AND COMPANY 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090483-A1 Purine derivatives as kinase inhibitors PNP, ADK, NME2 HTR1A 2208/4885DRD2 4440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.